Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index



      The Lee risk index was developed to predict major cardiac complications in noncardiac surgery. We retrospectively evaluated its ability to predict cardiovascular death in the large cohort of patients who recently underwent noncardiac surgery in our institution.


      The administrative database of the Erasmus MC, Rotterdam, The Netherlands, contains information on 108 593 noncardiac surgical procedures performed from 1991 to 2000. The Lee index assigns 1 point to each of the following characteristics: high-risk surgery, ischemic heart disease, heart failure, cerebrovascular disease, renal insufficiency, and diabetes mellitus. We retrospectively used available information in our database to adapt the Lee index calculated the adapted index for each procedure, and analyzed its relation to cardiovascular death.


      A total of 1877 patients (1.7%) died perioperatively, including 543 (0.5%) classified as cardiovascular death. The cardiovascular death rates were 0.3% (255/75 352) for Lee Class 1, 0.7% (196/28 892) for Class 2, 1.7% (57/3380) for Class 3, and 3.6% (35/969) for Class 4. The corresponding odds ratios were 1 (reference), 2.0, 5.1, and 11.0, with no overlap for the 95% confidence interval of each class. The C statistic for the prediction of cardiovascular mortality using the Lee index was 0.63. If age and more detailed information regarding the type of surgery was retrospectively added, the C statistic in this exploratory analysis improved to 0.85.


      The adapted Lee index was predictive of cardiovascular mortality in our administrative database, but its simple classification of surgical procedures as high-risk versus not high-risk seems suboptimal. Nevertheless, if the goal is to compare outcomes across hospitals or regions using administrative data, the use of the adapted Lee index, as augmented by age and more detailed classification of type of surgery, is a promising option worthy of prospective testing.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Heart Protection Study Collaborative Group
        MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals.
        Lancet. 2002; 360: 7-22
        • Dawood M.M.
        • Gutpa D.K.
        • Southern J.
        • et al.
        Pathology of fatal perioperative myocardial infarction.
        Int J Cardiol. 1996; 57: 37-44
        • Goldman L.
        • Caldera D.L.
        • Nussbaum S.R.
        • et al.
        Multifactorial index of cardiac risk in noncardiac surgical procedures.
        N Engl J Med. 1997; 297: 845-850
        • Zeldin R.A.
        Assessing cardiac risk in patients who undergo noncardiac surgical procedures.
        Can J Surg. 1984; 27: 402-404
        • Larsen S.F.
        • Olesen K.H.
        • Jacobsen E.
        • et al.
        Prediction of cardiac risk in non-cardiac surgery.
        Eur Heart J. 1987; 8: 179-185
        • Ashton C.M.
        • Petersen N.J.
        • Wray N.P.
        • et al.
        The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery.
        Ann Intern Med. 1993; 118: 504-510
        • Detsky A.S.
        • Abrams H.B.
        • McLaughlin J.R.
        • et al.
        Predicting cardiac complications in patients undergoing non-cardiac surgery.
        J Gen Intern Med. 1986; 1: 211-219
        • Lee T.H.
        • Marcantonio E.R.
        • Mangione C.M.
        • et al.
        Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
        Circulation. 1999; 100: 1043-1049
        • Mangano D.T.
        • Goldman L.
        Preoperative assessment of patients with known or suspected coronary disease.
        N Engl J Med. 1995; 333: 1750-1756
        • Eagle K.A.
        • Coley C.M.
        • Newell J.B.
        • et al.
        Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.
        Ann Intern Med. 1989; 110: 859-866
        • Boersma E.
        • Poldermans D.
        • Bax J.J.
        • et al.
        Predictors of cardiac events after major vascular surgery.
        JAMA. 2001; 285: 1865-1873
      1. ICD-9-CM: 2002:International Classification of Diseases, 9th Revision, Volumes 1 and 2. American Medical Association, 2001.

        • Eagle K.A.
        • Berger P.B.
        • Calkins H.
        • et al.
        American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery––executive summary report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
        Circulation. 2002; 105: 1257-1267
        • Kendal D.G.
        Rank Correlation Methods. Charles Griffin, London, England1962
        • Liang K.Y.
        • Zeger S.L.
        Longitudinal data analysis using general linear models.
        Biometrika. 1986; 73: 13-22
        • Eichhorn J.H.
        Prevention of intraoperative anesthesia accidents and related severe injury through safety monitoring.
        Anesthesiology. 1989; 70: 572-577
        • Lindenauer P.K.
        • Pekow P.
        • Wang K.
        • et al.
        Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.
        JAMA. 2004; 291: 2092-2099
        • Grayburn P.A.
        • Hillis L.D.
        Cardiac events in patients undergoing noncardiac surgery.
        Ann Intern Med. 2003; 138: 506-511
        • Ridley S.
        Cardiac scoring systems–what is their value?.
        Anaesthesia. 2003; 58: 985-991
        • Boersma E.
        • Pieper K.S.
        • Steyerberg E.W.
        • et al.
        Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation.
        Circulation. 2000; 101: 2557-2567
        • Iezzoni L.I.
        Using administrative diagnostic data to assess the quality of hospital care. Pitfalls and potential of ICD-9-CM.
        Int J Technol Assess Health Care. 1990; 6: 272-281
        • Mangano D.T.
        • Layug E.L.
        • Wallace A.
        • Tateo I.
        Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of the perioperative ischemia research group.
        N Engl J Med. 1997; 335: 1713-1720
        • Poldermans D.
        • Boersma E.
        • Bax J.J.
        • et al.
        The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.
        N Engl J Med. 1999; 341: 1789-1794
        • Poldermans D.
        • Bax J.J.
        • Kertai M.D.
        • et al.
        Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery.
        Circulation. 2003; 107: 1848-1851
        • Lindenauer P.K.
        • Pekow P.
        • Wang K.J.
        • et al.
        Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.
        JAMA. 2004; 291: 2092-2099
        • McFalls E.O.
        • Ward H.B.
        • Moritz T.E.
        • et al.
        Coronary-artery revascularization before elective major vascular surgery.
        N Engl J Med. 2004; 351: 2795-2804
        • Schouten O.
        • Polderman D.
        • Visser L.
        • et al.
        Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery.
        Am Heart J. 2004; 148: 1047-1052